172 related articles for article (PubMed ID: 35192693)
41. Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes.
Fernandez-Mercado M; Burns A; Pellagatti A; Giagounidis A; Germing U; Agirre X; Prosper F; Aul C; Killick S; Wainscoat JS; Schuh A; Boultwood J
Haematologica; 2013 Dec; 98(12):1856-64. PubMed ID: 23831921
[TBL] [Abstract][Full Text] [Related]
42. FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: verification of the method and application to 27 MDS patients.
Braulke F; Schanz J; Jung K; Shirneshan K; Schulte K; Schuetze C; Steffens R; Trümper L; Haase D
Leuk Res; 2010 Oct; 34(10):1296-301. PubMed ID: 20226527
[TBL] [Abstract][Full Text] [Related]
43. Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Nardi V; Hasserjian RP
Surg Pathol Clin; 2016 Mar; 9(1):143-63. PubMed ID: 26940274
[TBL] [Abstract][Full Text] [Related]
44. [Cytogenetic abnormalities of 50 MDS patients by FISH detection and conventional karyotype analysis].
Gao DG; Li BT; Zhou LN; Chen H; Zhang B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1190-4. PubMed ID: 24156432
[TBL] [Abstract][Full Text] [Related]
45. Maternal plasma genome-wide cell-free DNA can detect fetal aneuploidy in early and recurrent pregnancy loss and can be used to direct further workup.
Yaron Y; Pauta M; Badenas C; Soler A; Borobio V; Illanes C; Paz-Y-Miño F; Martinez-Portilla R; Borrell A
Hum Reprod; 2020 May; 35(5):1222-1229. PubMed ID: 32386059
[TBL] [Abstract][Full Text] [Related]
46. Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes.
He R; Wiktor AE; Durnick DK; Kurtin PJ; Van Dyke DL; Tefferi A; Patnaik MS; Ketterling RP; Hanson CA
Am J Clin Pathol; 2016 Jul; 146(1):86-94. PubMed ID: 27353768
[TBL] [Abstract][Full Text] [Related]
47. [Cytogenetics of myelodysplastic syndromes].
Laï JL; Fenaux P
Pathol Biol (Paris); 1997 Sep; 45(7):550-5. PubMed ID: 9404478
[TBL] [Abstract][Full Text] [Related]
48. [Progress of cytogenetic detection in myelodysplastic syndromes].
Zhou QB; Hu XM; Liu -; Ma R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1536-40. PubMed ID: 22169320
[TBL] [Abstract][Full Text] [Related]
49. Relapse and cytogenetic evolution in myeloid neoplasms.
Ertz-Archambault N; Kelemen K
Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
[TBL] [Abstract][Full Text] [Related]
50. The utility of a myeloid mutation panel for the diagnosis of myelodysplastic syndrome and myelodysplastic/myeloproliferative neoplasm.
Ibrar W; Zhang W; Cox JL; Cushman-Vokoun A; Fu K; Greiner TC; Yuan J
Int J Lab Hematol; 2021 Dec; 43(6):1501-1509. PubMed ID: 34270867
[TBL] [Abstract][Full Text] [Related]
51. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
52. Cytogenetic and comparative genomic hybridization study of Indian myelodysplastic syndromes.
Kawankar N; Jijina F; Ghosh K; Vundinti BR
Cancer Epidemiol; 2011 Aug; 35(4):e1-5. PubMed ID: 21193364
[TBL] [Abstract][Full Text] [Related]
53. Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability.
Nolte F; Giehl M; Haass W; Nowak V; Schumann C; Nowak D; Mossner M; Popp HD; Schulze TJ; Klein S; Seifarth W; Hofmann WK; Fabarius A
Ann Hematol; 2013 Oct; 92(10):1325-33. PubMed ID: 23645217
[TBL] [Abstract][Full Text] [Related]
54. Conventional cytogenetics and fluorescence in situ hybridization in persistent cytopenias and myelodysplastic syndromes in childhood.
Touliatou V; Kolialexi A; Tsangaris GT; Moschovi M; Polychronopoulou S; Mavrou A
Anticancer Res; 2004; 24(6):3945-9. PubMed ID: 15736436
[TBL] [Abstract][Full Text] [Related]
55. Longitudinal Shifts of Solid Tumor and Liquid Biopsy Sequencing Concordance in Metastatic Breast Cancer.
Liu MC; MacKay M; Kase M; Piwowarczyk A; Lo C; Schaeffer J; Finkle JD; Mason CE; Beaubier N; Blackwell KL; Park BH
JCO Precis Oncol; 2022 Jun; 6(1):e2100321. PubMed ID: 35721584
[TBL] [Abstract][Full Text] [Related]
56. Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients.
Romeo M; Chauffaille Mde L; Silva MR; Bahia DM; Kerbauy J
Leuk Res; 2002 Nov; 26(11):993-6. PubMed ID: 12363467
[TBL] [Abstract][Full Text] [Related]
57. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
[TBL] [Abstract][Full Text] [Related]
58. Diagnosis of myelodysplastic syndrome among a cohort of 119 patients with fanconi anemia: morphologic and cytogenetic characteristics.
Cioc AM; Wagner JE; MacMillan ML; DeFor T; Hirsch B
Am J Clin Pathol; 2010 Jan; 133(1):92-100. PubMed ID: 20023263
[TBL] [Abstract][Full Text] [Related]
59. Cytogenetic place in managing myelodysplastic syndromes: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Eclache V; Lafage-Pochitaloff M; Lefebvre C; Penther D; Raynaud S; Tigaud I
Ann Biol Clin (Paris); 2016 Oct; 74(5):525-534. PubMed ID: 27546835
[TBL] [Abstract][Full Text] [Related]
60. Severe Eosinophilia in Myelodysplastic Syndrome With a Defined and Rare Cytogenetic Abnormality.
Rai S; Espinoza JL; Morita Y; Tanaka H; Matsumura I
Front Immunol; 2018; 9():3031. PubMed ID: 30687305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]